Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens

被引:130
作者
Iwasaki, Masashi [3 ]
Tanaka, Yoshimasa [1 ,2 ]
Kobayashi, Hirohito [4 ]
Murata-Hirai, Kaoru
Miyabe, Hideto
Sugie, Tomoharu [5 ]
Toi, Masakazu [5 ]
Minato, Nagahiro [1 ,3 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan
[2] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Biostudies, Lab Immunol & Cell Biol, Kyoto, Japan
[4] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
[5] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan
关键词
gamma delta T cells; Phosphoantigen; PD-1; PD-L1; Tumor; NONPEPTIDE ANTIGENS; DILATED CARDIOMYOPATHY; MEDIATED RECOGNITION; ZOLEDRONIC ACID; TUMOR-CELLS; IN-VIVO; IMMUNOTHERAPY; RECEPTOR; B7-H1; PATHWAY;
D O I
10.1002/eji.201040959
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Programmed cell death-1 (PD-1) is an inhibitory receptor and plays an important role in the regulation of alpha beta T cells. Little is known, however, about the role of PD-1 in gamma delta T cells. In this study, we investigated the expression and function of PD-1 in human gamma delta T cells. Expression of PD-1 was rapidly induced in primary gamma delta T cells following antigenic stimulation, and the PD-1(+) gamma delta T cells produced IL-2. When PD-1(+) gamma delta T cells were stimulated with Daudi cells with and without programmed cell death ligand-1 (PD-L1) expression, the levels of IFN-gamma production and cytotoxicity in response to PD-L1(+) Daudi cells were diminished compared to the levels seen in response to PD-L1(-) Daudi cells. The attenuated effector functions were reversed by anti-PD-L1 mAb. When PD-L1(+) gamma delta T cells were challenged by PD-L1(+) tumors pretreated with zoledronate (Zol), which induced gamma delta TCR-mediated signaling, the resulting reduction in cytokine production was only slight to moderate compared to the reduction seen when PD-L1(+) gamma delta T cells were challenged by PD-L1(-) tumors. In addition, cytotoxic activity of PD-L1(+) gamma delta T cells against Zol-treated PD-L1(+) tumors was comparable to that against Zol-treated PD-L1(-) tumors. These results suggest that TCR triggering may partially overcome the inhibitory effect of PD-1 in gamma delta T cells.
引用
收藏
页码:345 / 355
页数:11
相关论文
共 50 条
  • [1] Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
    Ahmadzadeh, Mojgan
    Johnson, Laura A.
    Heemskerk, Bianca
    Wunderlich, John R.
    Dudley, Mark E.
    White, Donald E.
    Rosenberg, Steven A.
    [J]. BLOOD, 2009, 114 (08) : 1537 - 1544
  • [2] Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells
    Asslan, R
    Pradines, A
    Pratx, C
    Allal, C
    Favre, G
    Le Gaillard, F
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 260 (03) : 699 - 706
  • [3] Sensing cell stress and transformation through Vγ9Vδ2 T cell-mediated recognition of the isoprenoid pathway metabolites
    Bonneville, M
    Fournié, JJ
    [J]. MICROBES AND INFECTION, 2005, 7 (03) : 503 - 509
  • [4] Human Vγ9Vδ2 T cells:: promising new leads for immunotherapy of infections and tumors
    Bonneville, Marc
    Scotet, Emmanuel
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (05) : 539 - 546
  • [5] BUKOWSKI JF, 1995, J IMMUNOL, V154, P998
  • [6] Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity
    Chen, LP
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (05) : 336 - 347
  • [7] Gamma delta T cell receptors
    Chien, Y. -h.
    Bonneville, M.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (18) : 2089 - 2094
  • [8] STIMULATION OF HUMAN GAMMA-DELTA T-CELLS BY NONPEPTIDIC MYCOBACTERIAL LIGANDS
    CONSTANT, P
    DAVODEAU, F
    PEYRAT, MA
    POQUET, Y
    PUZO, G
    BONNEVILLE, M
    FOURNIE, JJ
    [J]. SCIENCE, 1994, 264 (5156) : 267 - 270
  • [9] Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
    Curiel, TJ
    Wei, S
    Dong, HD
    Alvarez, X
    Cheng, P
    Mottram, P
    Krzysiek, R
    Knutson, KL
    Daniel, B
    Zimmermann, MC
    David, O
    Burow, M
    Gordon, A
    Dhurandhar, N
    Myers, L
    Berggren, R
    Hemminki, A
    Alvarez, RD
    Emilie, D
    Curiel, DT
    Chen, LP
    Zou, WP
    [J]. NATURE MEDICINE, 2003, 9 (05) : 562 - 567
  • [10] Vγ2Vδ2 T-cell receptor-mediated recognition of aminobisphosphonates
    Das, H
    Wang, LS
    Kamath, A
    Bukowski, JF
    [J]. BLOOD, 2001, 98 (05) : 1616 - 1618